Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
239.04
+1.69 (0.71%)
Mar 6, 2026, 2:12 PM EST - Market open
Ascendis Pharma Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$278.80
Upside
+16.63%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +15.04% | Mar 3, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $246 → $262 | Buy | Maintains | $246 → $262 | +9.61% | Feb 12, 2026 |
| Wedbush | Wedbush | Buy Maintains $240 → $273 | Buy | Maintains | $240 → $273 | +14.21% | Feb 12, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $246 → $260 | Strong Buy | Maintains | $246 → $260 | +8.77% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $342 | Buy | Initiates | $342 | +43.07% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $245 → $250 | Buy | Maintains | $245 → $250 | +4.59% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $322 → $330 | Buy | Maintains | $322 → $330 | +38.05% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $297 → $322 | Buy | Maintains | $297 → $322 | +34.71% | Jan 9, 2026 |
| TD Cowen | TD Cowen | Strong Buy Reiterates $325 | Strong Buy | Reiterates | $325 | +35.96% | Jan 7, 2026 |
| Stifel | Stifel | Strong Buy Maintains $254 → $256 | Strong Buy | Maintains | $254 → $256 | +7.10% | Dec 11, 2025 |
| Wedbush | Wedbush | Buy Reiterates $220 | Buy | Reiterates | $220 | -7.97% | Nov 18, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $271 | Strong Buy | Initiates | $271 | +13.37% | Oct 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $203 → $254 | Buy | Maintains | $203 → $254 | +6.26% | Oct 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $260 → $264 | Buy | Maintains | $260 → $264 | +10.44% | Oct 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $227 → $230 | Strong Buy | Maintains | $227 → $230 | -3.78% | Sep 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $254 → $260 | Buy | Maintains | $254 → $260 | +8.77% | Aug 19, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.